يُستخدم الميرتازابين لعلاج اضطرابات الاكتئاب الشديدة. كما يُستخدم أيضًا لعلاج اضطراب الوسواس القهري واضطرابات القلق. الاكتئاب هو اضطراب مزاجي يتميز بالحزن أو عدم الرضا أو الغضب أو اليأس أو الشعور بالفقدان، مما يُعيق الأنشطة اليومية للشخص. يعمل الميرتازابين على تعزيز نشاط النواقل العصبية المسؤولة عن تحسين المزاج في الدماغ، مثل السيروتونين والنورأدرينالين، والتي تُسهّل التواصل بين خلايا الدماغ. ونتيجة لذلك، يُساعد على تحقيق التوازن في المزاج ويُخفف من أعراض الاكتئاب. في عام 1994، مُنحت هولندا أول ترخيص لهذا الدواء لعلاج الاكتئاب الشديد. وقد طورت شركة أورغانون هذا الدواء في البداية، وحصل على موافقة إدارة الغذاء والدواء الأمريكية في عام 1997 لعلاج اضطراب الاكتئاب الرئيسي.
BRAND NAMES
Remeron: It contains the active ingredients of mirtazapine. It is available in the form of oral film-coated tablets used to treat depression.
Remeron Sol Tab: It contains the active ingredients of mirtazapine. It is available in the form of disintegrated tablets used to treat depression.
MECHANISM OF ACTION
Mirtazapine is a tetracyclic antidepressant medication. Mirtazapine inhibits central presynaptic alpha-2-adrenergic receptors, enhancing serotonin and norepinephrine release. Mirtazapine is also known as a noradrenergic and selective serotonergic antidepressant. Noradrenaline is known to activate the sympathetic nervous system, which explains why mirtazapine causes general increases in activity and metabolism. It is also an effective antagonist of H1 histamine receptors 5-HT2A, 5-HT2C, and 5-HT3 serotonin receptors.
PHARMACOKINETICS
ABSORPTION
Mirtazapine is readily absorbed, reaching maximal plasma concentration in 2 hours. Food has a minor influence on both the rate and extent of absorption, necessitating no mirtazapine dose change.
DISTRIBUTION
In a pharmacokinetics investigation, the volume of distribution following an oral steady-state dose was found to be 107±42L.
METABOLISM
Mirtazapine is extensively metabolized in the liver by demethylation, hydroxylation, conjugation, and the cytochrome P450 enzyme. One of its key metabolites is desmethyl mirtazapine.
EXCRETION
The average elimination half-life of mirtazapine ranges from 20 to 40 hours. Mirtazapine metabolites are mostly eliminated in urine (75%), with feces accounting for 15%.
PHARMACODYNAMICS
Mirtazapine is a conventional antidepressant that is primarily used to treat severe depressive disorders. Mirtazapine belongs to the class of antidepressants known as tetracyclics. Mirtazapine inhibits central presynaptic alpha-2-adrenergic receptors, enhancing serotonin and norepinephrine release.
DOSAGE AND ADMINISTRATION
Mirtazapine is available in two forms: tablets and disintegrating tablets for oral use. It is typically taken once per day at bedtime. It can be taken with or without meals. Mirtazapine tablets are available in strengths of 7.5 mg, 15 mg, 30 mg, and 45 mg.
They are disintegrating tablets in strengths of 15 mg, 30 mg, and 45 mg.
DRUG INTERACTIONS
Drug interaction of mirtazapine includes
CONTRAINDICATIONS
You shouldn't use mirtazapine if you have an allergy to any of its constituents. Mirtazapine should not be given to patients undergoing intravenous methylene blue or linezolid due to the increased risk of serotonin syndrome.
SIDE EFFECTS
Mirtazapine side effects may include
Some serious side effects may include
OVERDOSE
Common overdose symptoms include
TOXICITY
Activated charcoal should be given during an overdose to absorb excess Mirtazapine. General supportive therapy should be used, including maintaining an adequate airway. Oxygen and ventilation therapy.